Joel is focused on identifying new investment opportunities in Precision Medicine, Artificial Intelligence, Population Health, Real World Evidence & Health Equity with a focus on Oncology, Vaccines and Infectious Disease.
Joel currently serves on the Boards of Arcadia Healthcare Solutions, CancerIQ and Infectious Disease Connect and is a Board Observer to Verana Health, GNS Healthcare and RxVantage. Joel also manages GHI’s investment in Unite Us and serves as GHI’s representative to Health Tech Capital. Joel volunteers as a guest lecturer in venture capital at Princeton University, serves as a Venture Mentor to NYU’s Stern School of Business and the Cedars-Sinai Digital Health Accelerator and is a frequent panelist and
moderator at industry events including HiMSS and HLTH.
Mr. Krikston has over 25 years of experience in healthcare innovation. Prior to joining Merck GHI in 2013, he was an Investor at Johnson & Johnson Development Corporation where he served on the Boards of GetWell Network and Imacor. Joel also spent over eight years as an investment banker, covering an array of healthcare clients and included experience at BNP Paribas, JPMorgan and ABN Amro.
Joel has an MBA with honors from the Stern School of Business at NYU and completed his Bachelor’s degree in Finance and International Business at Fairfield University. Mr. Krikston was recognized as a “Rising Star” by Global Corporate Venturing in 2017.